缘于可逆性脑血管收缩综合征的头痛研究进展

doi:10.3969/j.issn.1673-5765.2022.05.003

摘要/Abstract

摘要： 可逆性脑血管收缩综合征（reversible cerebral vasoconstriction syndrome，RCVS）是一种脑血管疾病，霹雳性头痛是其最主要的临床表现。缘于RCVS的头痛发病机制尚未明确。本文介绍了缘于 RCVS的头痛可能与血管张力失调和内皮功能障碍有关，同时从临床表现和鉴别诊断方面进行疾病的早期识别，从而早期干预以利于疾病的预后转归。

文章导读： 缘于RCVS的头痛的发病机制与血管张力失调和内皮功能障碍有关，难点在于对霹雳性头痛的识别诊断，探讨其发病机制和掌握鉴别诊断，有利于疾病的早诊早治。

关键词: 可逆性脑血管收缩综合征; 头痛; 发病机制; 早期诊治

Abstract: Reversible cerebral vasoconstriction syndrome (RCVS) is a kind of cerebrovascular disease. Headache due to RCVS is relatively common in RCVS patients, and the pathogenesis is not yet clear. In this paper, headache due to RCVS may be related to vascular dystonia and endothelial dysfunction, and early identification of the disease on the basis of clinical manifestations and differential diagnosis is conductive to the prognosis of the disease.

Key words: Reversible cerebral vasoconstriction syndrome; Headache; Pathogenesis; Early diagnosis and treatment

刘永辉, 杨侃, 覃福斌, 陈雯雯, 何婷婷, 黄雅帝. 缘于可逆性脑血管收缩综合征的头痛研究进展[J]. 中国卒中杂志, 2022, 17(05): 455-460.

LIU Yonghui, YANG Kan, QIN Fubin, CHEN Wenwen, HE Tingting, HUANG Yadi. Progress of Headache due to Reversible Cerebral Vasoconstriction Syndrome[J]. Chinese Journal of Stroke, 2022, 17(05): 455-460.

参考文献

[1] CALABRESE L H，DODICK D W，SCHWEDT T J，et al. Narrative review：reversible cerebral vasoconstriction syndromes[J]. Ann Intern Med，2007，146（1）：34-44.
[2] Hea d ache Cla ssif icat ion Com m it tee of t he International Headache Society（IHS）T he International Classification of Headache Disorders，3rd edition[J]. Cephalalgia，2018，38（1）：1-211.
[3] GRUNDT B，BOLLING T，RITCH M L. Reversible cerebral vasoconstriction syndrome：a common occurrence but rare diagnosis[J/OL]. Cureus，2020，12（6）：e8546[2021-12-04]. https://doi.org/10.7759/cureus.8546.
[4] SINGHAL A B，TOPCUOGLU M A，FOK J W，et al. Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system：clinical，imaging，and angiographic comparison[J]. Ann Neurol，2016，79（6）：882-894.
[5] MILLER T R，SHIVASHANKAR R，MOSSABASHA M，e t a l . R e v e r s i b l e c e r e b r a l vasoconstriction syndrome，part 1：epidemiology，pathogenesis，and clinical course[J]. AJNR Am J Neuroradiol，2015，36（8）：1392-1399.
[6] COFFINO S W，FRYER R H. Reversible cerebral vasoconstriction syndrome in pediatrics：a case series and review[J]. J Child Neurol，2017，32（7）：614-623.
[7] KIM T，AHN S，SOHN C H，et al. Reversible cerebral vasoconstriction syndrome at the emergency department[J]. Clin Exp Emerg Med，2015，2（4）：203-209.
[8] LING Y H，WANG Y F，LIRNG J F，et al. Postreversible cerebral vasoconstriction syndrome headache[J/OL]. J Headache Pain，2021，22（1）：14[2021-12-04]. https://doi.org/10.1186/s10194-021-01223-9.
[9] DUCROS A. Reversible cerebral vasoconstriction syndrome [J]. Lancet Neurol，2012，11（10）：906-917.
[10] TAKEMARU M，TAKESHIMA S，HARA N，et al. Reversible cerebral vasoconstriction syndrome：a clinical study of 11 cases[J]. Rinsho Shinkeigaku，2018，58（6）：377-384．
[11] 陈越，周仁兰. 可逆性脑血管收缩综合征的诊治进展[J]. 中风与神经疾病杂志，2019，36（5）：460-463.
[12] ARRIGAN M T，HERAN M K S，SHEWCHUK J R. Reversible cerebral vasoconstriction syndrome：an important and common cause of thunderclap and recurrent headaches[J]. Clin Radiol，2018，73（5）：417-427.
[13] TAKATA T，KUME K，KOKUDO Y，et al. Acute intermittent porphyria presenting with posterior reversible encephalopathy syndrome，accompanied by prolonged vasoconstriction [J]. Intern Med，2017，56（6）：713-717.
[14] JAMALI S A，ROZEN T D. An RCVS spectrum disorder? New daily persistent headache starting as a single thunderclap headache（3 new cases）[J]. Headache，2019，59（5）：789-794.
[15] YEBOAH K，BITTAR J，ALMAJALI M，et al. Transfusion-related acute brain injury：a case report on reversible cerebral vasoconstriction syndrome [J/OL]. Cureus，2020，12（7）：e9077[2021-12-04]. https://doi.org/10.7759/cureus.9077.
[16] MADHOK J，KLOOSTERBOER A，VENKATASUBRAMANIAN C，et al. Catecholamine-induced cerebral vasospasm and multifocal infarctions in pheochromocytoma[J/OL]. Endocrinol Diabetes Metab Case Rep，2020，2020：20-0078[2021-12-04]. https://doi.org/10.1530/EDM-20-0078.
[17] CHEN S P，FUH J L，LIRNG J F，et al. Recurrence of reversible cerebral vasoconstriction syndrome：a long-term follow-up study[J]. Neurology，2015，84（15）：1552-1558.
[18] KATO Y，HAYASHI T，MIZUNO S，et al. Triptaninduced reversible cerebral vasoconstriction syndrome：two case reports with a literature review[J]. Intern Med，2016，55（23）：3525-3528.
[19] KATO Y，HAYASHI T，SANO H，et al. Cough headache presenting with reversible cerebral vasoconstriction syndrome[J]. Intern Med，2018，57（10）：1459-1461.
[20] TOPCUOGLU M A，CHAN S T，SILVA G S，et al. Cerebral vasomotor reactivity in reversible cerebral vasoconstriction syndrome[J]. Cephalalgia，2017，37（6）：541-547．
[21] CHEN S P，FUH J L，WANG S J. Reversible cerebral vasoconstriction syndrome：current and future perspectives[J]. Expert Rev Neurother，2011，11（9）：1265-1276.
[22] CAPPELEN-SMITH C，CALIC Z，CORDATO D. Reversible cerebral vasoconstriction syndrome：recognition and treatment[J/OL]. Curr Treat Options Neurol，2017，19（6）：21[2021-12-04]. https://doi. org/10.1007/s11940-017-0460-7.
[23] SHEIKH H U，MATHEW P G. Reversible cerebral vasoconstriction syndrome：updates and new perspectives[J/OL]. Curr Pain Headache Rep，2014，18（5）：414[2021-12-04]. https://doi.org/10.1007/s11916-014-0414-7.
[24] SANTOS L，AZEVEDO E. Reversible cerebral vasoconstriction syndrome-a narrative revision of the literature[J]. Porto Biomed J，2016，1（2）：65-71.
[25] VERMA S，BUCHANAN M R，ANDERSON T J. Endothelial function testing as a biomarker of vascular disease[J]. Circulation，2003，108（17）：2054-2059.
[26] CHEN S P，WANG Y F，HUANG P H，et al. Reduced circulating endothelial progenitor cells in reversible cerebral vasoconstriction syndrome[J]. J Headache Pain，2014，15（1）：82[2021-12-04]. https://doi.org/10.1186/1129-2377-15-82.
[27] CHOI H A，LEE M J，CHUNG C S. Cerebral endothelial dysfunction in reversible cerebral vasoconstriction syndrome：a case-control study[J/OL]. J Headache Pain，2017，18（1）：29[2021-12-04]. https://doi.org/10.1186/s10194-017-0738-x.
[28] JOHN S，HAJJ-ALI R A，MIN D，et al. Reversible cerebral vasoconstriction syndrome：is it more than just cerebral vasoconstriction?[J]. Cephalalgia，2015，35（7）：631-634.
[29] MILLER T R，SHIVASHANKAR R，MOSSABASHA M，et al. Reversible cerebral vasoconstriction syndrome，part 2：diagnostic work-up，imaging evaluation，and differential diagnosis[J]. AJNR Am J Neuroradiol，2015，36（9）：1580-1588.
[30] CHEN S P，FUH J L，WANG S J，et al. Brainder ived neu rot rophic factor gene Val66Met polymor phism modulates reversible cerebral vasoconstriction syndromes[J/OL]. PLoS One，2011，6（3）：e18024[2021-12-04]. https://doi.org/10.1371/journal.pone.0018024.
[31] D E B - C H A T T E R J I M ，SCHUSTER S ，HAEUSSLER V，et al. Primary angiitis of the central nervous system：new potential imaging techniques and biomarkers in blood and cerebrospinal fluid[J/OL]. Front Neurol，2019，10：568[2021-12-04]. https://doi.org/10.3389/fneur.2019.00568.
[32] ZUCCOLI G，PIPITONE N，HALDIPUR A，et al. Imaging findings in primary central nervous system vasculitis[J/OL]. Clin Exp Rheumatol，2011，29（1 Suppl 64）：S104-S109[2021-12-04]. https://pubmed.ncbi.nlm.nih.gov/21586204/.
[33] DE BOYSSON H，ZUBER M，NAGGARA O，et al. Primary angiitis of the central nervous system：description of the first fifty-two adults enrolled in the French cohort of patients with primary vasculitis of the central nervous system[J]. Arthritis Rheumatol，2014，66（5）：1315-1326.
[34] SALVARANI C，BROWN R D JR，CALAMIA K T，et al. Primary central nervous system vasculitis：analysis of 101 patients[J]. Ann Neurol，2007，62（5）：442-451.
[35] MARCOLINI E，HINE J. Approach to the diagnosis and management of subarachnoid hemorrhage[J]. West J Emerg Med，2019，20（2）：203-211.
[36] DE OLIVEIRA MANOEL A L，MANSUR A，MURPHY A，et al. Aneurysmal subarachnoid haemorrhage from a neuroimaging perspective[J/OL]. Crit Care，2014，18（6）：557[2021-12-04]. https://doi.org/10.1186/s13054-014-0557-2.
[37] ZUURBIER S M，MIDDELDORP S，STAM J，et al. Sex differences in cerebral venous thrombosis：a systematic analysis of a shift over time[J]. Int J Stroke，2016，11（2）：164-170.
[38] LUO Y X，TIAN X，WANG X F. Diagnosis and treatment of cerebral venous thrombosis：a review[J/OL]. Front Aging Neurosci，2018，10：2[2021-12-04]. https://doi.org/10.3389/fnagi.2018.00002.
[39] 冯子凌. 颅内静脉系统血栓形成的临床诊疗分析[J]. 中国药物与临床，2018，18（11）：1966-1968.
[40] VAN OS H J，MULDER I A，VAN DER SCHAAF I C，et al. Role of atherosclerosis，clot extent，and penumbra volume in headache during ischemic stroke[J]. Neurology，2016，87（11）：1124-1130.
[41] HARRIOTT A M，KARAKAYA F，AYATA C. Headache after ischemic stroke：a systematic review and meta-analysis[J/OL]. Neurology，2020，94（1）：e75-e86[2021-12-04]. https://doi.org/10.1212/WNL.0000000000008591.
[42] C HO S，LEE M J，C H U NG C S. Ef fe c t of nimodipine treatment on the clinical course of reversible cerebral vasoconstriction syndrome[J/OL]. Front Neurol，2019，10：644[2021-12-04]. https://doi.org/10.3389/fneur.2019.00644.
[43] ROZEN T D，BEAMS J L. New daily persistent headache with a thunderclap headache onset and complete response to nimodipine（a new distinct subtype of NDPH）[J/OL]. J Headache Pain，2013，14（1）：100[2021-12-04]. https://doi.org/10.1186/1129-2377-14-100.
[44] MIJALSKI C，DAKAY K，MILLER-PATTERSON C，et al. Magnesium for treatment of reversible cerebral vasoconstriction syndrome：case series[J]. Neurohospitalist，2016，6（3）：111-113.
[45] SONG J K，FISHER S，SEIFERT T D，et al. Postpartum cerebral angiopathy：atypical features and treatment with intracranial balloon angioplasty[J]. Neuroradiology，2004，46（12）：1022-1026.
[46] BOUCHARD M，VERREAULT S，GARIÉPY J L，et al. Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome[J]. Headache，2009，49（1）：142-145.
[47] GRÄNDE P O，LUNDGREN A，BJARTMARZ H，et al. Segmental cerebral vasoconstriction：successful treatment of secondary cerebral ischaemia with intravenous prostacyclin[J]. Cephalalgia，2010，30（7）：890-895.
[48] DUCROS A. Le syndrome de vasoconstriction cérébrale réversible[ Reversible cerebral vasoconstriction syndrome][J]. Rev Neurol（Paris），2010，166（4）：365-376.